Keywords: GLP-1RAs, GLP-1/GIP dual receptor agonist, tirzepatide, clinical pharmacology, T2DM, obesity, neuroprotection Introduction Glucagon-like peptide-1 (GLP-1) is a small-peptide hormone
Our biggest concern was reducing those comorbidities and the long-term impact that that has on the cost of insurance in general, because more comorbidities means more claims, Arnold said, referring to diseases and conditions associated with obesity
PMID 19640223
30 minutes before workout
The pharmaceutical industry has welcomed a host of therapies and vaccines into this revered club, with indications covering everything from cancer and covid-19 to arthritis and atrial fibrillation. In 1986, 10 years after it was first introduced by Smith Kline & French, sales of peptic ulcer treatment Tagamet (cimetidine) surpassed the $1 billion mark, making it the first drug in history to be classified as a blockbuster.2 Since then, the pharmaceutical industry has welcomed a host of therapies and vaccines into this revered club, with indications covering everything from cancer and covid-19 to arthritis and atrial fibrillation
